Existing Drugs Combine To Fight World’s Most Common Liver Disease

Drug repurposing offers a promising and cost-effective strategy for developing new treatments. Metabolic dysfunction-associated steatotic liver disease is now recognized as the most widespread liver disorder globally, affecting roughly one in three adults. The condition develops when fat builds up inside liver cells, which can lead to serious liver damage and is strongly linked to […]

Source link